The clinical effects of the terazosin and Qianlieshu capsule treatment of type III prostatitis

Objectives To investigate the clinical effects of the terazosin Qianlieshu capsule treatment of type Ⅲ prostatitis.Methods 120 patients with type Ⅲ prostatitis patients were divided into observation group and control group were treated with terazsin (2 mg,1 night) + (3 capsules Qianlieshu capsule three times daily) and hydrochloric acid terazosin (2 mg,1 night) treatment,after 8 weeks in accordance with the U.S.National Institutes of Health (NIH) to develop prostate symptom score ( CPSI ),quality of life (QOL) score and prostatic fluid routine.Results After eight weeks of treatment,observation group and control group of the NIH-CPSI score,QOL in score and EPS conventional leukocyte count are significantly decreased( P ＜0.01 ),but the degree of decline in the observation group than in the control group significantly( P ＜ 0.01 ).Conclusions Terazosin forefront of spironolactone capsules in treatment of prostatitis type Ⅲ terazosin efficacy than the single is worthy of clinical. Key words: Prostatitis; Prazosin